Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 138.90
Bid: 138.80
Ask: 139.30
Change: 0.00 (0.00%)
Spread: 0.50 (0.36%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 138.90
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Debt

25 Feb 2021 18:04

RNS Number : 4227Q
Aston Martin Lagonda Global Hld PLC
25 February 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,

DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

OF AMERICA, CANADA, JAPAN OR AUSTRALIA

 

 

25 February 2021

 

ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC ANNOUNCES THE PRICING OF $98.5 MILLION (£70m EQUIVALENT) AGGREGATE PRINCIPAL AMOUNT OF 10.5% SENIOR SECURED NOTES DUE 2025 BY ITS SUBSIDIARY

 

Aston Martin Lagonda Global Holdings plc announces that its subsidiary, Aston Martin Capital Holdings Limited (the "Issuer"), successfully priced $98.5 million (£70m equivalent) aggregate principal amount of 10.5% Senior Secured Notes due 2025 (the "Notes") issued at 109%, a premium which generates gross proceeds to the Issuer of $107.4 million (£76m equivalent). The offering of the Notes is subject to customary closing conditions and settlement is expected to occur on or around 4 March 2021. The proceeds from the offering of Notes, if completed, will be used for general corporate purposes, including working capital, capital expenditures and to pay expenses and fees in connection with the offering of the Notes.

 

The Notes constitute a further issuance of Aston Martin Capital Holdings Limited's 10.50% Senior Secured Notes due 2025 issued in November 2020 (the "Existing Notes") and will have the same terms as those of the Existing Notes. Both issuances of notes will constitute a single class of debt security under the Indenture dated 16 November 2020, including with respect to waivers, amendments, redemptions and offers to purchase. The Notes offered in reliance on Rule 144A will be immediately fungible with the Existing Notes issued in reliance on Rule 144A. The Notes offered in reliance on Regulation S under the U.S. Securities Act will initially bear a temporary CUSIP and temporary ISIN that differ from those of the Existing Notes issued in reliance on Regulation S, but will become fully fungible after the time period specified in Regulation S, which is expected to be 40 days after the issue date of the Notes.

 

 

Enquiries

Investors and Analysts

Charlotte Cowley Director of Investor Relations +44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie Corporate Communications Manager +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington +44 (0)20 73534200

 

 

Cautionary Statement

 

The Notes will be offered only to qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons outside the United States pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act"), subject to prevailing market and other conditions. There is no assurance that the offering will be completed or, if completed, as to the terms on which it is completed. The Notes to be offered have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold, directly or indirectly, in the United States or to or for the account or benefit of U.S. persons, as such term is defined in Regulation S of the Securities Act, absent registration or unless pursuant to an applicable exemption from the registration requirements of the Securities Act and any other applicable securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any EEA retail investor in the European Economic Area ("EEA"). For these purposes, the term EEA retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation"). Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to EEA retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any EEA retail investor in the EEA may be unlawful under the PRIIPs Regulation. This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the Prospectus Regulation. The offer and sale of the Notes will be made pursuant to an exemption under the Prospectus Regulation from the requirement to produce a prospectus for offers of securities. This announcement is not a prospectus for the purposes of the Prospectus Regulation.

 

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any UK retail investor in the United Kingdom ("UK"). For these purposes, the term UK retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (as amended, "FSMA") and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA ("UK MiFIR"); or (iii) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA (the "UK Prospectus Regulation"). Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the "UK PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to UK retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any UK retail investor in the UK may be unlawful under the UK PRIIPs Regulation. This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the UK Prospectus Regulation. The offer and sale of the Notes will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to produce a prospectus for offers of securities. This announcement is not a prospectus for the purposes of the UK Prospectus Regulation.

 

The manufacturer target market (MIFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels).

 

This communication does not constitute an offer of securities to the public in the United Kingdom and is being distributed only to, and is directed only at persons who are qualified investors (as defined in the Prospectus Regulation) who are (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"), or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) persons to whom it would otherwise be lawful to distribute them, all such persons together being referred to as "Relevant Persons." Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this communication or any of its contents.

 

Forward-Looking Statements

 

This press release may include forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", ‟estimates", ‟anticipates", "expects", ‟intends", ‟may", ‟will" or "should" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding the Issuer's or its affiliates' intentions, beliefs or current expectations concerning, among other things, the Issuer's or its affiliates' results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which they operate. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and that the Issuer's or its affiliates' actual results of operations, financial condition and liquidity, and the development of the industries in which they operate may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition, even if the Issuer's or its affiliates' results of operations, financial condition and liquidity, and the development of the industries in which they operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODSEEFAIEFSESE
Date   Source Headline
12th Aug 202110:58 amRNSDirector/PDMR Shareholding
3rd Aug 20212:35 pmRNSDirector/PDMR Shareholding
29th Jul 202110:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSInterim results for the six months to 30 June 2021
26th Jul 20217:00 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSAdditional Listing
15th Jul 20217:00 amRNSAdditional Listing
8th Jul 20217:00 amRNSDirectorate Change
29th Jun 20212:00 pmRNSDirector/PDMR Shareholding
29th Jun 202110:45 amRNSTotal Voting Rights
22nd Jun 20217:00 amRNSCommencement of legal proceedings
16th Jun 20212:00 pmRNSDirector/PDMR Shareholding
15th Jun 202111:06 amRNSDirector/PDMR Shareholding
28th May 20219:30 amRNSTotal Voting Rights
25th May 20211:00 pmRNSResult of AGM
10th May 202111:00 amRNSDirector/PDMR Shareholding
6th May 20217:00 amRNS1st Quarter Results
29th Apr 20219:30 amRNSTotal Voting Rights
21st Apr 20219:30 amRNSNotice of AGM
19th Apr 20217:15 amRNSDeath of Non-Executive Director
6th Apr 20211:45 pmRNSDirector Declaration - Correction
6th Apr 20211:00 pmRNSDirector Declaration
30th Mar 202110:30 amRNSTotal Voting Rights
11th Mar 202111:34 amRNSAnnual Financial Report
3rd Mar 20212:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20219:30 amRNSDirector/PDMR Shareholding
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20216:04 pmRNSIssue of Debt
25th Feb 202110:30 amRNSIssue of Debt
25th Feb 20217:00 amRNSFinal Results
19th Feb 20211:32 pmRNSDirectorate Change
28th Jan 202112:25 pmRNSTotal Voting Rights
28th Jan 20219:00 amRNSDirectorate Change
30th Dec 202010:00 amRNSTotal Voting Rights
29th Dec 20209:00 amRNSHolding(s) in Company
15th Dec 20209:30 amRNSDirector/PDMR Shareholding
10th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20204:43 pmRNSDirector/PDMR Shareholding - Replacement
9th Dec 20201:30 pmRNSDirector/PDMR Shareholding
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20209:17 amRNSHolding(s) in Company
7th Dec 20207:00 amRNSAdmission of Placing and Consideration Shares
4th Dec 20209:51 amRNSResult of the General Meeting
30th Nov 202010:00 amRNSTotal Voting Rights
26th Nov 20209:31 amRNSSatisfaction of Antitrust Conditions
18th Nov 20201:40 pmRNSPublication of a Prospectus
13th Nov 20203:25 pmRNSDirectorate Change
5th Nov 20202:00 pmRNSDirector/PDMR Shareholding
30th Oct 20205:25 pmRNSPricing of Senior Secured Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.